Sight is vital to our health and well-being.
In fact, people fear vision loss more than losing hearing, memory, speech or even a limb. Vision research is helping every day — producing exciting new insights about eye disease, developing innovations to restore sight, and driving clinical breakthroughs that are helping all of us see the future more clearly.
IN THE NEWS
Aflibercept Won’t Help Vision In Early Diabetic Retinopathy, Medscape, March 31, 2021
Turning Back The Clock On A Severe Vision Disorder, Penn Today, March 30, 2021
Preventive Treatment Reduces Diabetic Retinopathy Complications, National Eye Institute, March 30, 2021
Dry Eye Disease: Not Tearing Up Can Tear You Down
DED can cause pain, blurriness, and inflammation, can even injure your cornea, and recent studies demonstrate that the damage doesn’t stop there. They reveal that individuals with DED find it harder to perform simple tasks such driving or getting dressed; experience significant pain that interferes with social relationships; and report increased anxiety, depression, and poor overall health. Experts estimate that more than 340 million adults globally and 34 million in the United States live with this condition.
Visionary Scientist
Lotfi Merabet, OD, PhD, MPH, is a clinician scientist and a member of the Vision Rehabilitation Service at Massachusetts Eye and Ear. His research focuses on diagnosis and rehabilitation approaches for children with cerebral visual impairment (CVI) and how the brain changes due to ocular or cerebral causes of blindness.
“RPB Lunch & Learn: Eye on Low Vision,” April 29, 1:00pm ET
Research to Prevent Blindness (RPB) is holding the next installment of its virtual Lunch & Learn series on Thursday, April 29 at 1:00pm ET. This event will focus on low vision, featuring RPB grantees discussing their latest research in this area. Previous Lunch & Learns have focused on Age-Related Macular Degeneration, Glaucoma, and Diabetic Retinopathy.
To RSVP, please contact events@rpbusa.org.
VISION RESEARCH IS AN INVESTMENT IN A BETTER FUTURE
As NIH Director Frances Collins put it, “Due to the architecture, accessibility, and the elegance of the eye, vision research has always been a few steps ahead in biomedical research.”